MediWound Announces Submission of Biologics License Application to the U.S. FDA for NexoBrid for the Treatment of Severe Thermal Burns

Ads

You May Also Like

ADMA Biologics Receives PDUFA Date for BIVIGAM® Regulatory Submission

Prior Approval Supplement (“PAS”) to Amend the Biologics License Application (“BLA”) for BIVIGAM® is ...

Final patient receives treatment in stem cell clinical trial for severe blood cancers

MONTREAL, June 27, 2018 (GLOBE NEWSWIRE) -- ExCellThera Inc., a biotechnology company delivering molecules ...